These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


194 related items for PubMed ID: 17074483

  • 1. Kynurenic acid amides as novel NR2B selective NMDA receptor antagonists.
    Borza I, Kolok S, Galgóczy K, Gere A, Horváth C, Farkas S, Greiner I, Domány G.
    Bioorg Med Chem Lett; 2007 Jan 15; 17(2):406-9. PubMed ID: 17074483
    [Abstract] [Full Text] [Related]

  • 2. New benzoyl urea derivatives as novel NR2B selective NMDA receptor antagonists.
    Borza I, Greiner I, Kolok S, Galgóczy K, Ignácz-Szendrei G, Horváth C, Farkas S, Gáti T, Háda V, Domány G.
    Pharmazie; 2006 Sep 15; 61(9):799-800. PubMed ID: 17020160
    [Abstract] [Full Text] [Related]

  • 3. Benzimidazole-2-carboxamides as novel NR2B selective NMDA receptor antagonists.
    Borza I, Kolok S, Gere A, Nagy J, Fodor L, Galgóczy K, Fetter J, Bertha F, Agai B, Horváth C, Farkas S, Domány G.
    Bioorg Med Chem Lett; 2006 Sep 01; 16(17):4638-40. PubMed ID: 16782335
    [Abstract] [Full Text] [Related]

  • 4. Selective NR1/2B N-methyl-D-aspartate receptor antagonists among indole-2-carboxamides and benzimidazole-2-carboxamides.
    Borza I, Bozó E, Barta-Szalai G, Kiss C, Tárkányi G, Demeter A, Gáti T, Háda V, Kolok S, Gere A, Fodor L, Nagy J, Galgóczy K, Magdó I, Agai B, Fetter J, Bertha F, Keserü GM, Horváth C, Farkas S, Greiner I, Domány G.
    J Med Chem; 2007 Mar 08; 50(5):901-14. PubMed ID: 17290978
    [Abstract] [Full Text] [Related]

  • 5. Structure-activity relationship of N-(phenylalkyl)cinnamides as novel NR2B subtype-selective NMDA receptor antagonists.
    Tamiz AP, Cai SX, Zhou ZL, Yuen PW, Schelkun RM, Whittemore ER, Weber E, Woodward RM, Keana JF.
    J Med Chem; 1999 Aug 26; 42(17):3412-20. PubMed ID: 10464027
    [Abstract] [Full Text] [Related]

  • 6. Oxamides as novel NR2B selective NMDA receptor antagonists.
    Barta-Szalai G, Borza I, Bozó E, Kiss C, Agai B, Proszenyák A, Keseru GM, Gere A, Kolok S, Galgóczy K, Horváth C, Farkas S, Domány G.
    Bioorg Med Chem Lett; 2004 Aug 02; 14(15):3953-6. PubMed ID: 15225705
    [Abstract] [Full Text] [Related]

  • 7. Structure-activity relationship study of novel NR2B-selective antagonists with arylamides to avoid reactive metabolites formation.
    Kawai M, Sakurada I, Morita A, Iwamuro Y, Ando K, Omura H, Sakakibara S, Masuda T, Koike H, Honma T, Hattori K, Takashima T, Mizuno K, Mizutani M, Kawamura M.
    Bioorg Med Chem Lett; 2007 Oct 15; 17(20):5537-42. PubMed ID: 17766107
    [Abstract] [Full Text] [Related]

  • 8. Indole-2-carboxamides as novel NR2B selective NMDA receptor antagonists.
    Borza I, Kolok S, Gere A, Agai-Csongor E, Agai B, Tárkányi G, Horváth C, Barta-Szalai G, Bozó E, Kiss C, Bielik A, Nagy J, Farkas S, Domány G.
    Bioorg Med Chem Lett; 2003 Nov 03; 13(21):3859-61. PubMed ID: 14552795
    [Abstract] [Full Text] [Related]

  • 9. A novel series of benzimidazole NR2B-selective NMDA receptor antagonists.
    Davies DJ, Crowe M, Lucas N, Quinn J, Miller DD, Pritchard S, Grose D, Bettini E, Calcinaghi N, Virginio C, Abberley L, Goldsmith P, Michel AD, Chessell IP, Kew JN, Miller ND, Gunthorpe MJ.
    Bioorg Med Chem Lett; 2012 Apr 01; 22(7):2620-3. PubMed ID: 22366657
    [Abstract] [Full Text] [Related]

  • 10. Identification and characterization of 4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an orally bioavailable, brain penetrant NR2B selective N-methyl-D-aspartate receptor antagonist.
    Liverton NJ, Bednar RA, Bednar B, Butcher JW, Claiborne CF, Claremon DA, Cunningham M, DiLella AG, Gaul SL, Libby BE, Lyle EA, Lynch JJ, McCauley JA, Mosser SD, Nguyen KT, Stump GL, Sun H, Wang H, Yergey J, Koblan KS.
    J Med Chem; 2007 Feb 22; 50(4):807-19. PubMed ID: 17249648
    [Abstract] [Full Text] [Related]

  • 11. NR2B-selective N-methyl-D-aspartate antagonists: synthesis and evaluation of 5-substituted benzimidazoles.
    McCauley JA, Theberge CR, Romano JJ, Billings SB, Anderson KD, Claremon DA, Freidinger RM, Bednar RA, Mosser SD, Gaul SL, Connolly TM, Condra CL, Xia M, Cunningham ME, Bednar B, Stump GL, Lynch JJ, Macaulay A, Wafford KA, Koblan KS, Liverton NJ.
    J Med Chem; 2004 Apr 08; 47(8):2089-96. PubMed ID: 15056006
    [Abstract] [Full Text] [Related]

  • 12. ACEA-1011, a novel NMDA receptor/glycine site antagonist, produces antinociception but not tolerance in the formalin test in mice.
    Lutfy K, Keana JF, Weber E.
    NIDA Res Monogr; 1995 Apr 08; 147():220-33. PubMed ID: 8742789
    [No Abstract] [Full Text] [Related]

  • 13. [Analgesic effect of kynurenic acid].
    Kékesi G, Horváth G.
    Ideggyogy Sz; 2002 Sep 20; 55(9-10):313-22. PubMed ID: 12503245
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and evaluation of N-(3-oxo-2,3-dihydro-1H-pyrazol-4-yl)-1H-indole-carboxamides as cholecystokinin antagonists.
    Lattmann E, Singh H, Boonprakob Y, Lattmann P, Sattayasai J.
    J Pharm Pharmacol; 2006 Mar 20; 58(3):393-401. PubMed ID: 16536908
    [Abstract] [Full Text] [Related]

  • 15. Development of 3-substituted-1H-indole derivatives as NR2B/NMDA receptor antagonists.
    Gitto R, De Luca L, Ferro S, Citraro R, De Sarro G, Costa L, Ciranna L, Chimirri A.
    Bioorg Med Chem; 2009 Feb 15; 17(4):1640-7. PubMed ID: 19157884
    [Abstract] [Full Text] [Related]

  • 16. Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
    Tewes B, Frehland B, Schepmann D, Schmidtke KU, Winckler T, Wünsch B.
    Bioorg Med Chem; 2010 Nov 15; 18(22):8005-15. PubMed ID: 20965739
    [Abstract] [Full Text] [Related]

  • 17. Kynurenic acid derivatives. Structure-activity relationships for excitatory amino acid antagonism and identification of potent and selective antagonists at the glycine site on the N-methyl-D-aspartate receptor.
    Leeson PD, Baker R, Carling RW, Curtis NR, Moore KW, Williams BJ, Foster AC, Donald AE, Kemp JA, Marshall GR.
    J Med Chem; 1991 Apr 15; 34(4):1243-52. PubMed ID: 1826744
    [Abstract] [Full Text] [Related]

  • 18. Design, Synthesis, and Biological Evaluation of 3-Benzazepin-1-ols as NR2B-Selective NMDA Receptor Antagonists.
    Tewes B, Frehland B, Schepmann D, Schmidtke KU, Winckler T, Wünsch B.
    ChemMedChem; 2010 May 03; 5(5):687-95. PubMed ID: 20340125
    [Abstract] [Full Text] [Related]

  • 19. Tonic facilitation of glutamate release by glycine binding sites on presynaptic NR2B-containing NMDA autoreceptors in the rat visual cortex.
    Li YH, Han TZ, Meng K.
    Neurosci Lett; 2008 Feb 27; 432(3):212-6. PubMed ID: 18248890
    [Abstract] [Full Text] [Related]

  • 20. Indole-2-carboxamidines as novel NR2B selective NMDA receptor antagonists.
    Borza I, Kolok S, Ignácz-Szendrei G, Greiner I, Tárkányi G, Galgóczy K, Horváth C, Farkas S, Domány G.
    Bioorg Med Chem Lett; 2005 Dec 15; 15(24):5439-41. PubMed ID: 16213709
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.